Marlise Luskin, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML (NCT03595917) | Marlise Luskin, MD | 2018-07-24 |
Track Marlise Luskin, MD automatically
Every clearance here is in the API, with alerts when new ones post.